Efficacy and Safety of Docetaxel in Elderly Patients With Metastatic Castration-Resistant Prostate Cancer

PURPOSE: Limited data are available about the tolerability and clinical outcomes of elderly patients with metastatic castration-resistant prostate cancer (mCRPC) who are treated with docetaxel. We evaluated the efficacy and safety of docetaxel as first-line chemotherapy for patients with mCRPC who w...

Descripción completa

Detalles Bibliográficos
Autores principales: Maia, Manuel Caitano, Pereira, Allan A. Lima, Lage, Liana Valente, Fraile, Natalia Moreno, Vaisberg, Victor Van, Kudo, Guilherme, Barroso-Sousa, Romualdo, Bastos, Diogo Assed, Dzik, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2017
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180794/
https://www.ncbi.nlm.nih.gov/pubmed/30241182
http://dx.doi.org/10.1200/JGO.2016.007807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180794/
https://www.ncbi.nlm.nih.gov/pubmed/30241182
http://dx.doi.org/10.1200/JGO.2016.007807

Ejemplares similares